These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 35887639)

  • 21. Glomerular Hyperfiltration Interacts With Abnormal Metabolism to Enhance Arterial Stiffness in Middle-Aged and Elderly People.
    Zhai Q; Wen J; Wang M; Zuo Y; Su X; Zhang Y; Gaisano H; He Y
    Front Med (Lausanne); 2021; 8():732413. PubMed ID: 34746175
    [No Abstract]   [Full Text] [Related]  

  • 22. The correlation between fatty liver disease and chronic kidney disease.
    Chen PC; Kao WY; Cheng YL; Wang YJ; Hou MC; Wu JC; Su CW
    J Formos Med Assoc; 2020 Jan; 119(1 Pt 1):42-50. PubMed ID: 30876789
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Nonalcoholic Fatty Liver Disease Associates With Increased Overall Mortality and Death From Cancer, Cardiovascular Disease, and Liver Disease in Women but Not Men.
    Hwang YC; Ahn HY; Park SW; Park CY
    Clin Gastroenterol Hepatol; 2018 Jul; 16(7):1131-1137.e5. PubMed ID: 29158157
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evaluated Glomerular Filtration Rate Is Associated With Non-alcoholic Fatty Liver Disease: A 5-Year Longitudinal Cohort Study in Chinese Non-obese People.
    Cen J; Han Y; Liu Y; Hu H
    Front Nutr; 2022; 9():916704. PubMed ID: 35782950
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Association Between 10-Year Fracture Probability and Nonalcoholic Fatty Liver Disease With or Without Sarcopenia in Korean Men: A Nationwide Population-Based Cross-Sectional Study.
    Lee HJ; Lee DC; Kim CO
    Front Endocrinol (Lausanne); 2021; 12():599339. PubMed ID: 33868162
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Nonalcoholic fatty liver disease increases risk of incident chronic kidney disease: A systematic review and meta-analysis.
    Mantovani A; Zaza G; Byrne CD; Lonardo A; Zoppini G; Bonora E; Targher G
    Metabolism; 2018 Feb; 79():64-76. PubMed ID: 29137912
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Glomerular Hyperfiltration Is Associated with Liver Disease Severity in Children with Nonalcoholic Fatty Liver Disease.
    Yodoshi T; Arce-Clachar AC; Sun Q; Fei L; Bramlage K; Xanthakos SA; Flores F; Mouzaki M
    J Pediatr; 2020 Jul; 222():127-133. PubMed ID: 32381466
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Non-alcoholic fatty liver disease and clinical outcomes in chronic kidney disease.
    Chinnadurai R; Ritchie J; Green D; Kalra PA
    Nephrol Dial Transplant; 2019 Mar; 34(3):449-457. PubMed ID: 29390103
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Persistent Nonalcoholic Fatty Liver Disease Increases Risk for Carotid Atherosclerosis.
    Sinn DH; Cho SJ; Gu S; Seong D; Kang D; Kim H; Yi BK; Paik SW; Guallar E; Cho J; Gwak GY
    Gastroenterology; 2016 Sep; 151(3):481-488.e1. PubMed ID: 27283259
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Fibrosis stage is the strongest predictor for disease-specific mortality in NAFLD after up to 33 years of follow-up.
    Ekstedt M; Hagström H; Nasr P; Fredrikson M; Stål P; Kechagias S; Hultcrantz R
    Hepatology; 2015 May; 61(5):1547-54. PubMed ID: 25125077
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Role of non-alcoholic fatty liver disease in the evolution of renal function in patients with diabetes mellitus.
    Aubert L; Sandino J; Gutiérrez-Solís E; García-Martín F; Segura J; Porrini E; Morales E
    Nephrol Dial Transplant; 2022 May; 37(6):1125-1131. PubMed ID: 33983444
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Association of non-alcoholic fatty liver disease with chronic kidney disease: a systematic review and meta-analysis.
    Musso G; Gambino R; Tabibian JH; Ekstedt M; Kechagias S; Hamaguchi M; Hultcrantz R; Hagström H; Yoon SK; Charatcharoenwitthaya P; George J; Barrera F; Hafliðadóttir S; Björnsson ES; Armstrong MJ; Hopkins LJ; Gao X; Francque S; Verrijken A; Yilmaz Y; Lindor KD; Charlton M; Haring R; Lerch MM; Rettig R; Völzke H; Ryu S; Li G; Wong LL; Machado M; Cortez-Pinto H; Yasui K; Cassader M
    PLoS Med; 2014 Jul; 11(7):e1001680. PubMed ID: 25050550
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Natural History of Non-Alcoholic Fatty Liver Disease: A Study With Paired Liver Biopsies.
    Reddy YK; Marella HK; Jiang Y; Ganguli S; Snell P; Podila PSB; Maliakkal B; Satapathy SK
    J Clin Exp Hepatol; 2020; 10(3):245-254. PubMed ID: 32405181
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A cohort study on Helicobacter pylori infection associated with nonalcoholic fatty liver disease.
    Kim TJ; Sinn DH; Min YW; Son HJ; Kim JJ; Chang Y; Baek SY; Ahn SH; Lee H; Ryu S
    J Gastroenterol; 2017 Nov; 52(11):1201-1210. PubMed ID: 28382402
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Progression and new onset of nonalcoholic fatty liver disease in living kidney donors compared to healthy controls.
    Katchman H; Zelber-Sagi S; Baruch R; Berman G; Schwartz IF; Schwartz D; Nakache R; Goykhman Y; Katz P; Shibolet O; Shashar M; Grupper A
    Clin Transplant; 2018 May; 32(5):e13240. PubMed ID: 29575023
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Liver and Cardiovascular Damage in Patients With Lean Nonalcoholic Fatty Liver Disease, and Association With Visceral Obesity.
    Fracanzani AL; Petta S; Lombardi R; Pisano G; Russello M; Consonni D; Di Marco V; Cammà C; Mensi L; Dongiovanni P; Valenti L; Craxì A; Fargion S
    Clin Gastroenterol Hepatol; 2017 Oct; 15(10):1604-1611.e1. PubMed ID: 28554682
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Metabolically healthy versus unhealthy obesity and risk of fibrosis progression in non-alcoholic fatty liver disease.
    Kim Y; Chang Y; Cho YK; Ahn J; Shin H; Ryu S
    Liver Int; 2019 Oct; 39(10):1884-1894. PubMed ID: 31226232
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cohort study of non-alcoholic fatty liver disease, NAFLD fibrosis score, and the risk of incident diabetes in a Korean population.
    Chang Y; Jung HS; Yun KE; Cho J; Cho YK; Ryu S
    Am J Gastroenterol; 2013 Dec; 108(12):1861-8. PubMed ID: 24100261
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Nonalcoholic fatty liver disease and advanced fibrosis are associated with left ventricular diastolic dysfunction.
    Chung GE; Lee JH; Lee H; Kim MK; Yim JY; Choi SY; Kim YJ; Yoon JH; Kim D
    Atherosclerosis; 2018 May; 272():137-144. PubMed ID: 29604480
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Increased Risk for Cardiovascular Events in Patients with Diabetic Kidney Disease and Non-Alcoholic Fatty Liver Disease.
    Chinnadurai R; Chrysochou C; Kalra PA
    Nephron; 2019; 141(1):24-30. PubMed ID: 30384370
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.